XtalPi
XtalGazer integrates prediction, automated experiments, SCXRD, and MicroED for solid-state research.
All cataloged profiles, sources, filters, and comparisons are open. Sign in to save companies, keep private notes, and join discussions.
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
24 matching companies
XtalGazer integrates prediction, automated experiments, SCXRD, and MicroED for solid-state research.
WuXi STA and WuXi Chemistry offer solid-form screening, polymorph quantification, structural analysis, and crystallization process development.
CMC materials science services include solid-state and physicochemical characterization and polymorph, salt, and cocrystal screening.
Focuses on solid-state R&D, including polymorph, salt, and cocrystal screening, crystallization process development, and structural characterization using complementary techniques.
CDMO solid-state services can be contracted independently or integrated with API and drug product development, including salt and polymorph selection.
A U.S. solid-state R&D and analytical CRO offering solid-form screening, structural characterization, and intellectual-property-related studies.
Pharmorphix solid-state and particle engineering services are now part of Veranova, spanning screening, crystallization development, and analytical support.
A European CDMO offering polymorph, salt, cocrystal, and amorphous-form screening and crystallization development.
A contract provider focused on solid-state and particle characterization and analytical development for small-molecule drugs. Historical directory descriptions are not treated as evidence of a current comprehensive screening service.
Almac Sciences' physical sciences services cover polymorph, salt, and cocrystal screening, crystallization development, and preformulation.
A Japanese CMC contract research company combining solid-form selection with high-throughput nucleation, competitive slurry conversion, and structure determination.
API development and manufacturing integrate crystallization engineering, salt selection, and polymorph screening.
Eurofins CDMO offers high-throughput polymorph, salt, and cocrystal screening and crystallization development.
Discovery and physical characterization services include pharmaceutical polymorph and salt screening.
API solid-form screening connects with crystallization process development to support physical stability, manufacturability, and drug development.
A Canadian CRO specializing in solid-state science and crystallization engineering, including polymorph, salt, and cocrystal screening and process optimization.
A Spanish solid-state and chemical R&D CRO offering screening, characterization, and scale-up of polymorphs, cocrystals, salts, and solvates.
A solid-form screening and preclinical development CRO combining experimental screening with computational methods; MicroED is offered through its XtalPi partnership.
Uses mSAS supercritical-fluid technology for crystal and particle engineering and enhanced polymorph screening.
The CRO/CDMO solid-state team offers discovery, screening, crystallization development, and evaluation of new API solid forms.
An Ipca-owned small-molecule CDMO offering solid-state chemistry, salt and cocrystal screening, and chiral resolution support.
CMC solid-state characterization and form-selection services; the website discloses salt screening and XRPD analysis.
Offers phase-appropriate comprehensive solid-form screening, single-crystal growth, structure determination, and crystallization process development.
A CRDMO offering salt and polymorph screening and solid-state characterization, with a disclosed dedicated solid-state laboratory.
Coverage expands from sourced records; this database does not claim all biopharma companies.